COVID-19 took over the world in 2020 but getting reliable data to understand its effect on cancer takes time—usually 2 to 3 years using traditional population-based data sources like state cancer registries.
Until data started becoming available, researchers had to find innovative ways to gather some facts.
These images and text are a sample of American Cancer Society (快猫短视频) studies published in 2021 based on data found in both traditional and less familiar ways. They show the beginnings of how the COVID-19 pandemic is affecting the continuum of cancer care.
In less than 2 months?after the United States identified its first cases of COVID-19, there were?more than 100,000 cases?and?2,000 deaths.
Everyone attempted to prevent the virus from spreading:
Disruptions in health care have affected the full range of cancer care?and care for others who may have a higher risk for being hospitalized and dying from coronavirus infection. The pandemic has also increased the risk for people with cancer or with a history of it to have a?reduced quality of life?due to cancer worry, health anxiety, depression, and inactivity.
In most states, the COVID-19 pandemic hasn't helped increase the low lung-cancer screening rates of people eligible for a yearly low-dose computed tomography (LDCT).
Surprisingly, though, when 快猫短视频 researchers?compared screening rates between 2019 and 2020, they found?19 states had improved screening rates—with Kentucky having the most improvement.
"Kentucky's screening implementation efforts led to rates?more than 2 times the national average?and?4 times that of?West Virginia and Arkansas,?other high lung-cancer burden states.”
—Robert Smith, PhD, study co-author and?快猫短视频 Senior Vice President, Cancer Screening
?
If this was helpful, donate to help fund patient support services, research, and cancer content updates.